Zenas BioPharma adopts amended Short-Term Incentive Plan for annual cash bonuses

Zenas BioPharma, Inc.

Plan effective Jan 1, 2026; provides discretionary annual cash bonuses based on company and individual performance.
Target awards expressed as percentage of base salary; payouts capped at 150% of target.
Employees hired after Sep 30 generally ineligible; must be employed through payment date.
Administered by Board for executives and by CEO/leadership for other employees.
Company retains right to amend or discontinue plan at any time.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.